Widespread implementation of cytology-based screening programs has resulted in marked declines in cervical cancer incidence and mortality in the United States. Nonetheless, an estimated 13 240 women will be diagnosed with cervical cancer in 2018, and 4170 will die from the disease.1 It is likely that a sizable proportion of these women will not have been appropriately screened.2
Sawaya GF. Cervical Cancer Screening—Moving From the Value of Evidence to the Evidence of Value. JAMA Intern Med. 2018;178(10):1293–1295. doi:10.1001/jamainternmed.2018.4282
Best of JAMA Network 2022
Customize your JAMA Network experience by selecting one or more topics from the list below.